Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France

Atherosclerosis

Volumn 150, Issue 1, 2000, Pages 149-157

  Dallongeville, Jean ^a   Meirhaeghe, Aline ^a   Cottel, Dominique ^a   Fruchart, Jean Charles ^a   Amouyel, Philippe ^a   Helbecque, Nicole ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Apolipoprotein C III; Cholesterol; Dyslipidemia; Genetics; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Polymorphism; Triglycerides

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN C; APOLIPOPROTEIN C3; INSULIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD; FEMALE; FRANCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; HYPERLIPIDEMIA; MALE; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGED; ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS C; FEMALE; FRANCE; HUMANS; HYPERLIPIDEMIAS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; VARIATION (GENETICS);

EID: 0034185685     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00362-7     Document Type: Article

References (36)

1. Mahley RW, Innerarity TL, Rall SCJ, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984;25:1277-94.
2. Talmud PJ, Humphries SE. Apolipoprotein C-III gene variation and dyslipidaemia. Curr Opin Lipidol 1997;8:154-8.
3. Peacock RE, Temple A, Gudnason V, Rosseneu M, Humphries SE. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Genet Epidemiol 1997;14:265-82.
4. Porkka KV, Taimela S, Kontula K, Lehtimaki T, Aalto-Setala K, Akerblom HK, Viikari JS. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study. Clin Genet 1994;45:113-21.
5. Anderson RA, Burns TL, Lee J, Swenson D, Bristow JL. Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population. Atherosclerosis 1989;77:227-37.
6. Kessling A, Ouellette S, Bouffard O, Chamberland A, Betard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: influence of gender and exogenous hormones. Am J Hum Genet 1991;50:92-106.
7. Aalto-Setala K, Viikari J, Akerblom HK, Kuusela V, Kontula K. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. J Lipid Res 1991;32:1477-87.
8. Xu CF, Nanjee MN, Savill J, Talmud PJ, Angelico F, Del Ben M, Antonini R, Mazzarella B, Miller N, Humphries SE. Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet 1990;47:429-39.
9. Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre PA, Cox NJ. Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet 1996;98:557-66.
10. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol 1997;17:2753-8.
11. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997;17:1060-6.
12. Hoffer MJ, Sijbrands EJ, De Man FH, Havekes LM, Smelt AH, Frants RR. Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the Sstl polymorphism. Eur J Clin Invest 1998;28:807-12.
13. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, Chiang CW, Lee YS. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 1997;100:327-33.
14. Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996;16:941-7.
15. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 1993;90:4562-6.
16. Henderson HE, Landon SV, Michie J, Berger GM. Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes. Hum Genet 1987;75:62-5.
17. Stocks J, Paul H, Galton D. Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-I C-III A-IV gene region and hypertriglyceridemia. Am J Hum Genet 1987;41:106-18.
18. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest 1985;76:1090-5.
19. Ribalta J, La Ville AE, Vallve JC, Humphries S, Turner PR, Masana L. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia. J Lipid Res 1997;38:1061-9.
20. Dallinga-Thie GM, van Linde-Sibenius T, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TW. Complex genetic contribution of the Apo AI-CII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. J Clin Invest 1997;99:953-61.
21. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994;94:2377-84.
22. Xu CF, Talmud P, Schuster H, Houlston R, Miller G, Humphries S. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin Genet 1994;46:385-97.
23. Dallinga-Thie GM, Bu XD, van Linde-Sibenius T, Rotter JI, Lusis AJ, de Bruin TW. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res 1996;37:136-47.
24. Wijsman EM, Brunzell JD, Jarvik GP, Austin MA, Motulsky AG, Deeb SS. Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler Thromb Vasc Biol 1998;18:215-26.
25. Tahvanainen E, Pajukanta P, Porkka K, Nieminen S, Ikavalko L, Nuotio I, Taskinen MR, Peltonen L, Ehnholm C. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1998;18:1810-7.
26. Marcil M, Boucher B, Gagne E, Davignon J, Hayden M, Genest JJ. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. J Lipid Res 1996;37:309-19.
27. Hong SH, Park WH, Lee CC, Song JH, Kim JQ. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 1997;43:13-7.
28. Kee F, Amouyel P, Arveiler D, Cambou JP, Ducimetiere P, Evans A, Fruchart JC, Cambien F, Dallongeville J. Lack of association between genetic variations of apo A-I,C-III,A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis 1999;145:187-95.
29. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
30. Helbecque N, Dallongeville J, Codron V, Arveiler D, Ruidavets JB, Evans A, Cambien F, Fruchart JC, Amouyel P. The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans. Arterioscler Thromb Vasc Biol 1997;17:2759-64.
31. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
32. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
33. McLean CJ, Morton NE. Estimation of myriad haplotype frequencies. Genet Epidemiol 1985;2:263-72.
34. Cox NJ, Bell GI, Xiang KS. Linkage disequilibrium in the human insulin/insulin-like growth factor II region of human chromosome II. Am J Hum Genet 1988;43:495-501.
35. Xu CF, Angelico F, Del Ben M, Humphries S. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol 1993;10:113-22.
36. Haviland MB, Kessling AM, Davignon J, Sing CF. Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis. Ann Hum Genet 1995;59:211-31.